7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one has been researched along with Migraine Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garret, C; Le Prado, N; Moussaoui, SM; Philippe, L | 1 |
| Diener, HC; Effert, R; Goadsby, PJ; Hargreaves, RJ; Knorr, M; May, A; Shepheard, SL; Wessing, A | 1 |
2 other study(ies) available for 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one and Migraine Disorders
| Article | Year |
|---|---|
Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580.
Topics: Animals; Capsaicin; Dose-Response Relationship, Drug; Dura Mater; Guinea Pigs; Indoles; Inflammation; Injections, Intravenous; Isoindoles; Male; Meninges; Migraine Disorders; Rats; Rats, Wistar; Stereoisomerism; Substance P | 1993 |
Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.
Topics: Adult; Aged; Animals; Blood Vessels; Capillary Permeability; Choroid; Electric Stimulation; Female; Humans; Indoles; Isoindoles; Male; Middle Aged; Migraine Disorders; Plasma; Rats; Retinal Vessels; Sumatriptan; Vasoconstrictor Agents | 1998 |